Phase IB trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in patients with advanced pancreatic cancer (PC) Meeting Abstract
| Authors: | Lowery, M. A.; Harding, J. J.; Yu, K. H.; Kelsen, D. P.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; Johnston, A.; Liu, K. C. W.; Capanu, M.; Abou-Alfa, G. K.; O'Reilly, E. M. |
| Abstract Title: | Phase IB trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in patients with advanced pancreatic cancer (PC) |
| Meeting Title: | 2017 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Jan 19-21 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-02-01 |
| Language: | English |
| ACCESSION: | WOS:000443281700287 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2017.35.4_suppl.295 |
| Notes: | Meeting Abstract: 295 -- Source: Wos |
